78 related articles for article (PubMed ID: 1465339)
1. [Hydralazine-induced enhancement of hyperthermia treatment in vivo].
Oshima T; Akagi K; Hasegawa T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov; 52(11):1582-8. PubMed ID: 1465339
[TBL] [Abstract][Full Text] [Related]
2. [Effect of hydralazine on the blood flow of normal and tumor tissues in hyperthermia].
Ohshima T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):960-9. PubMed ID: 8371944
[TBL] [Abstract][Full Text] [Related]
3. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
[TBL] [Abstract][Full Text] [Related]
5. [Study of anti-tumor effects of hyperthermia combined with hydralazine on experimental tumor].
Aoki Y; Akagi K; Kitada N; Tanaka Y; Fritz-Zieroth B
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Nov; 55(14):987-92. PubMed ID: 8570396
[TBL] [Abstract][Full Text] [Related]
6. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors.
Kalmus J; Okunieff P; Vaupel P
Cancer Res; 1990 Jan; 50(1):15-9. PubMed ID: 2293549
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of thermal damage in murine tumors by hydralazine-induced modification of blood flow and oxygen tension.
Aoki Y; Akagi K; Oshima T; Isoda H; Nasu R; Shiga T; Murata T; Tanaka Y
Int J Oncol; 1997 Nov; 11(5):1123-8. PubMed ID: 21528313
[TBL] [Abstract][Full Text] [Related]
9. Hydralazine at thermoradiotherapy: tumor size and blood flow effects.
Kozin SV; Hasegawa T; Ha-Kawa SK; Akagi K; Tanaka Y
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):505-10. PubMed ID: 8005807
[TBL] [Abstract][Full Text] [Related]
10. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
Horsman MR; Christensen KL; Overgaard J
Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180
[TBL] [Abstract][Full Text] [Related]
11. Hydralazine combined with hyperthermia enhances the effects of carboquone.
Emi Y; Maehara Y; Kusumoto T; Baba H; Takahashi I; Yoshida M; Sugimachi K
Oncology; 1994; 51(4):339-43. PubMed ID: 8208517
[TBL] [Abstract][Full Text] [Related]
12. Vasoacting agents flavone acetic acid and hydralazine given in combination enhance antitumor effects under condition of hyperthermia.
Yamamoto M; Kusumoto T; Endo K; Baba H; Sakaguchi Y; Maehara Y; Sugimachi K
Oncology; 1996; 53(2):147-52. PubMed ID: 8604241
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel and hyperthermia: factors that modify thermal enhancement.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
J Surg Oncol; 2004 Oct; 88(1):14-20. PubMed ID: 15384091
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of thermal sensitivity of xenografted human DLD-2 tumors by administration of basic fibroblast growth factor.
Leith JT
Radiat Res; 1994 Apr; 138(1):139-42. PubMed ID: 8146294
[TBL] [Abstract][Full Text] [Related]
15. Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor.
Nishita T
Osaka City Med J; 1998 Jun; 44(1):73-83. PubMed ID: 9834620
[TBL] [Abstract][Full Text] [Related]
16. The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
Horsman MR; Overgaard J; Chaplin DJ
Acta Oncol; 1988; 27(6b):861-2. PubMed ID: 3233175
[No Abstract] [Full Text] [Related]
17. Treatment of murine SCC VII tumors with localized hyperthermia and temperature-sensitive liposomes containing cisplatin.
Nishimura Y; Ono K; Hiraoka M; Masunaga S; Jo S; Shibamoto Y; Sasai K; Abe M; Iga K; Ogawa Y
Radiat Res; 1990 May; 122(2):161-7. PubMed ID: 2336462
[TBL] [Abstract][Full Text] [Related]
18. Modification of radio-thermo-chemotherapy by AK-2123 and hydralazine in tumor bearing mice.
Kunugita N; Mei N; Norimura T; Kagiya TV
Indian J Exp Biol; 1996 Sep; 34(9):838-41. PubMed ID: 9014514
[TBL] [Abstract][Full Text] [Related]
19. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
Overgaard J; Radacic MM; Grau C
Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
[TBL] [Abstract][Full Text] [Related]
20. Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations.
Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Nagata K; Suzuki M; Kinashi Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):570-7. PubMed ID: 15380594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
